Chemoinformaics analysis of 1-O-(2-METHYLPROPYL) 2-O-PENTAN-2-YL BENZENE-1,2-DICARBOXYLATE
Molecular Weight | 292.375 | nRot | 7 |
Heavy Atom Molecular Weight | 268.183 | nRig | 1 |
Exact Molecular Weight | 292.167 | nRing | 1 |
Solubility: LogS | -6.821 | nHRing | 0 |
Solubility: LogP | 6.347 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 1 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 45 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 21 | No. of Aromatic Carbocycles | 1 |
nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 17 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
No. of Oxygen atom | 4 | No. of Arom Bond | 6 |
nHA | 4 | APOL | 47.601 |
nHD | 0 | BPOL | 29.285 |
QED | 0.384 |
Synth | 2.98 |
Natural Product Likeliness | 0.227 |
NR-PPAR-gamma | 0.264 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Accepted |
Pgp-inh | 0.769 |
Pgp-sub | 0.864 |
HIA | 0.002 |
CACO-2 | -4.666 |
MDCK | 0.0000204 |
BBB | 0.527 |
PPB | 0.981272 |
VDSS | 1.708 |
FU | 0.0145595 |
CYP1A2-inh | 0.123 |
CYP1A2-sub | 0.835 |
CYP2c19-inh | 0.105 |
CYP2c19-sub | 0.825 |
CYP2c9-inh | 0.194 |
CYP2c9-sub | 0.844 |
CYP2d6-inh | 0.003 |
CYP2d6-sub | 0.057 |
CYP3a4-inh | 0.042 |
CYP3a4-sub | 0.093 |
CL | 6.035 |
T12 | 0.053 |
hERG | 0.092 |
Ames | 0.049 |
ROA | 0.023 |
SkinSen | 0.94 |
Carcinogencity | 0.923 |
EI | 0.984 |
Respiratory | 0.935 |
NR-Aromatase | 0.677 |
Antiviral | Yes |
Prediction | 0.633675 |